Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
Did you know?
How did MoneyWorks4me help subscribers to buy IEX at Rs. 193/ share 1 year before?
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Gujarat Meditech Ltd Stock Analysis

Small Cap
Evaluated by 13 users | BSE: 524754 | NSE: |
Household & Personal Products

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18TTM
Return on Capital Employed 00.22%0.26%0.57%-0.04%0.01%0.01%00.01%0.01%-
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 00.20.30.30.3000.50.40.81
Y-o-Y Gr. Rt.-NA27.3%7.1%6.7%-90.6%0%1533.3%-10.2%70.5%-
Adjusted EPS (Rs.) 00.030.030.070000000.00
Y-o-Y Gr. Rt.-NA0%133.3%-100%NANANANANA-
Book Value per Share (Rs.) 09.6810.5110.5710.5710.5710.5710.5710.5710.5710.58
Adjusted Net Profit 00000000000
Net Op. Cash Flow (Rs. Cr.) 00000000.100-
Debt to Cash Flow from Ops 010.63-48.48.09-39.55512.7316.598.91-516.2211.3-
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Gujarat Meditech Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  10 yrs 5 yrs 3 yrs 1 yr
Net Sales NA18.6%192.4%70.5%
Adjusted EPS NANANANA
Book Value per Share 0000
Share Price -12.8% 11.2% 0.9% -
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18TTM
Return on Equity (%) 00.240.280.62-0.0400.0100.010.010
Operating Profit Margin (%) 014.79-2.0114.93-0.523.292.080.060.170.08-2.49
Net Profit Margin (%) 04.634.249.04-0.540.420.960.010.090.040
Debt to Equity 00.090.080.080.080.080.050.090.10.10.05
Working Capital Days 005,5005,4495,09255,93455,8123,5654,4412,716405
Cash Conversion Cycle 001733313321643-18-19-
Loading price chart...
Entity Percentage Holding
Promoters 8.98%
Non-Institutions 91.02%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

Gujarat Meditech Ltd's earnings have grown by 0%, whereas share price has appreciated 11.2% CAGR over the past five years, indicating the company’s share price is likely overvalued. However, for specific investment actions please consult your investment advisor.

Gujarat Meditech Ltd share price has declined -12.8% annually (CAGR) over the past ten years.

Data is not available for this company.

Gujarat Meditech was incorporated in 1991. The company is engaged in the business of manufacturing intraocular lenses.

The company has initiated a project to manufacture intraocular lenses in technical collaboration with IOL International. Commercial production has not taken off, and it is suspended from the BSE on account of non compliance with listing agreement clauses.

The registered office is located at 511, Golden Triangle, Sardar Patel Stadium Road, Ahmedabad in Gujarat.

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback